With a recent initial public offering, CEO Richard Foust hopes to make the company’s vagus nerve stimulation treatment the ...
Initiation of SLIM-1™ clinical trial, a Phase 1 study of NPM-139, a semaglutide implant under development for chronic weight ...
The increasing prevalence of chronic disorders, shift towards non-opioid-based treatment, technological advancement in device ...
Startups have developed chips that allow people to control machines with their thoughts. Billionaires are betting these brain ...
Researchers have been working for decades on so-called brain-computer interfaces to help people who suffer from paralysis, ...
ROCKAWAY, N.J., May 13, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness ...
Precise timing has confined effective neurorehab to clinics. Wearable, semi‑autonomous neurostimulation uses muscle signals ...
Shifting workforce dynamics, accelerating technology adoption and mounting financial pressure are testing the foundations of orthopedic care. Leaders from across the field shared what concerns them ...
More than 60 million Americans live with chronic pain, including 21 million who experience daily activity limitations, ...
Epineuron said FDA clearance marks a significant expansion of its portfolio. It also expands the commercial footprint of its ...
Hosted on MSN
VA invests $596M in upgrades as rehab sector grows
Record VA upgrades: The VA is directing $596 million into facility improvements in Q2, part of a $4.8 billion plan to modernize care for millions of veterans. Therapy network expansion: NYU Langone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results